RU2008151778A - Новые кристаллы 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил)метокси]фенил]пропиновой кислоты - Google Patents

Новые кристаллы 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил)метокси]фенил]пропиновой кислоты Download PDF

Info

Publication number
RU2008151778A
RU2008151778A RU2008151778/04A RU2008151778A RU2008151778A RU 2008151778 A RU2008151778 A RU 2008151778A RU 2008151778/04 A RU2008151778/04 A RU 2008151778/04A RU 2008151778 A RU2008151778 A RU 2008151778A RU 2008151778 A RU2008151778 A RU 2008151778A
Authority
RU
Russia
Prior art keywords
hydroxybenzoyl
cyclopentyloxy
methoxy
hydroxy
phenyl
Prior art date
Application number
RU2008151778/04A
Other languages
English (en)
Other versions
RU2429233C2 (ru
Inventor
Кендзи ЙОНЕЗАВА (JP)
Кендзи ЙОНЕЗАВА
Хиронори КОЦУБО (JP)
Хиронори КОЦУБО
Ясутака БАБА (JP)
Ясутака БАБА
Юкие ТАДА (JP)
Юкие ТАДА
Original Assignee
Тояма Кемикал Ко., Лтд. (Jp)
Тояма Кемикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тояма Кемикал Ко., Лтд. (Jp), Тояма Кемикал Ко., Лтд. filed Critical Тояма Кемикал Ко., Лтд. (Jp)
Publication of RU2008151778A publication Critical patent/RU2008151778A/ru
Application granted granted Critical
Publication of RU2429233C2 publication Critical patent/RU2429233C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

1. Кристаллы 3-{5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил)метокси]фенил}пропионовой кислоты, характеризующиеся пиками в положениях 14,0, 16,0, 23,3, 23,7 и 26,3° по оси угла дифракции 2θ на порошковой рентгенограмме. ! 2. Кристаллы 3-{5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил)метокси]фенил}пропионовой кислоты, характеризующиеся пиками в положениях 14,6, 23,1, 24,7, 25,6 и 26,0° по оси угла дифракции 2θ на порошковой рентгенограмме.

Claims (2)

1. Кристаллы 3-{5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил)метокси]фенил}пропионовой кислоты, характеризующиеся пиками в положениях 14,0, 16,0, 23,3, 23,7 и 26,3° по оси угла дифракции 2θ на порошковой рентгенограмме.
2. Кристаллы 3-{5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил)метокси]фенил}пропионовой кислоты, характеризующиеся пиками в положениях 14,6, 23,1, 24,7, 25,6 и 26,0° по оси угла дифракции 2θ на порошковой рентгенограмме.
RU2008151778/04A 2006-05-26 2007-05-25 Новые кристаллы 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил) метокси]фенил]пропионовой кислоты RU2429233C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-146220 2006-05-26
JP2006146220 2006-05-26

Publications (2)

Publication Number Publication Date
RU2008151778A true RU2008151778A (ru) 2010-07-10
RU2429233C2 RU2429233C2 (ru) 2011-09-20

Family

ID=38778516

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008151778/04A RU2429233C2 (ru) 2006-05-26 2007-05-25 Новые кристаллы 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил) метокси]фенил]пропионовой кислоты

Country Status (27)

Country Link
US (1) US7977492B2 (ru)
EP (1) EP2022788B1 (ru)
JP (1) JP5117381B2 (ru)
KR (1) KR101389038B1 (ru)
CN (1) CN101454298B (ru)
AT (1) ATE479666T1 (ru)
AU (1) AU2007268771B2 (ru)
BR (1) BRPI0712909A2 (ru)
CA (1) CA2652939C (ru)
CY (1) CY1111398T1 (ru)
DE (1) DE602007008882D1 (ru)
DK (1) DK2022788T3 (ru)
EC (1) ECSP089000A (ru)
ES (1) ES2351065T3 (ru)
HR (1) HRP20100544T1 (ru)
IL (1) IL195416A (ru)
MA (1) MA30510B1 (ru)
MX (1) MX2008014906A (ru)
NO (1) NO20084632L (ru)
NZ (1) NZ573034A (ru)
PL (1) PL2022788T3 (ru)
PT (1) PT2022788E (ru)
RS (1) RS51517B (ru)
RU (1) RU2429233C2 (ru)
SI (1) SI2022788T1 (ru)
WO (1) WO2007138996A1 (ru)
ZA (1) ZA200809922B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2562170T3 (pl) * 2006-02-21 2015-03-31 Toyama Chemical Co Ltd Sposób wytwarzania estru kwasu 3-{5-[4-(cyklopentyloksy)- 2-hydroksybenzoilo]-2-[(3-okso-2-podstawionego-2,3-dihydro-1,2-benzizoksazol-6-ilo)metoksy]fenylo}- propionowego i związku pośredniego dla sposobu
NZ588128A (en) * 2008-03-27 2012-12-21 Toyama Chemical Co Ltd USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF alpha INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
CN102014889A (zh) 2008-04-22 2011-04-13 富山化学工业株式会社 组合使用二苯甲酮衍生物或其盐和免疫抑制剂的方法以及包含这些组分的药物组合物
CN103183647B (zh) * 2011-12-28 2017-06-09 天津市国际生物医药联合研究院有限公司 3‑{[2‑[3‑氧‑(1,2‑苯并异噻唑‑6‑基)甲氧基‑5‑(2‑羟基‑4‑环戊氧基苯甲酰基)]苯基}丙酸的制备方法
CN118255728B (zh) * 2024-01-25 2024-07-30 中国医学科学院阜外医院 化合物的盐型晶型用于治疗射血分数保留的心衰的用途
CN118252824B (zh) * 2024-01-25 2024-09-17 中国医学科学院阜外医院 化合物用于治疗射血分数保留的心衰的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042150A (en) 1960-01-26 1962-07-03 Lukawsky Michael Emergency brake and anti-skid device
WO1995001964A1 (fr) * 1993-07-06 1995-01-19 Yamanouchi Pharmaceutical Co., Ltd. Nouveau cristal de derive de benzodiazepine
AU769778B2 (en) * 1998-11-05 2004-02-05 Toyama Chemical Co. Ltd. Novel compounds and pharmaceutical use thereof
JP4976617B2 (ja) * 2000-03-17 2012-07-18 富山化学工業株式会社 新規なベンゾフェノン誘導体およびその塩
JP4554926B2 (ja) 2001-11-16 2010-09-29 富山化学工業株式会社 新規なベンゾフェノン誘導体またはその塩

Also Published As

Publication number Publication date
BRPI0712909A2 (pt) 2012-10-02
KR101389038B1 (ko) 2014-04-28
DK2022788T3 (da) 2010-12-13
US7977492B2 (en) 2011-07-12
RS51517B (en) 2011-06-30
IL195416A (en) 2012-07-31
DE602007008882D1 (de) 2010-10-14
ES2351065T3 (es) 2011-01-31
MX2008014906A (es) 2008-12-09
ECSP089000A (es) 2009-02-27
KR20090014194A (ko) 2009-02-06
HRP20100544T1 (hr) 2010-11-30
AU2007268771B2 (en) 2011-12-01
ATE479666T1 (de) 2010-09-15
EP2022788A1 (en) 2009-02-11
SI2022788T1 (sl) 2011-01-31
RU2429233C2 (ru) 2011-09-20
EP2022788B1 (en) 2010-09-01
IL195416A0 (en) 2009-08-03
WO2007138996A1 (ja) 2007-12-06
PL2022788T3 (pl) 2011-03-31
CN101454298B (zh) 2011-11-16
CY1111398T1 (el) 2015-08-05
ZA200809922B (en) 2010-02-24
JPWO2007138996A1 (ja) 2009-10-08
EP2022788A4 (en) 2009-06-24
CA2652939C (en) 2014-12-02
AU2007268771A1 (en) 2007-12-06
US20090275757A1 (en) 2009-11-05
NO20084632L (no) 2008-12-12
JP5117381B2 (ja) 2013-01-16
CA2652939A1 (en) 2007-12-06
CN101454298A (zh) 2009-06-10
PT2022788E (pt) 2010-10-04
MA30510B1 (fr) 2009-06-01
NZ573034A (en) 2010-08-27

Similar Documents

Publication Publication Date Title
RU2008151778A (ru) Новые кристаллы 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1,2-бензизоксазол-6-ил)метокси]фенил]пропиновой кислоты
IL195417A0 (en) Oral composition comprising 3-[5-[4-(cyclopenthyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl) methoxy]phenyl]propionic acid or salt thereof
NZ592603A (en) Aryl gpr120 receptor agonists and uses thereof
AR109006A2 (es) Compuesto de oxazol y composición farmacéutica
AR081226A1 (es) Polimorfo cristalino de 4-[5-[3-cloro-5-(trifluorometil)fenil]-4,5-dihidro-5-(trifluorometil)-3-isoxazolil]-n-[2-oxo-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalenocarboxamida
JP2008044952A5 (ru)
ZA200802636B (en) Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE)
TW200736195A (en) Methods for preparing sulfonamide substituted alcohols and intermediates thereof
CL2008002038A1 (es) Compuestos derivados de 3-fenil-1,2-oxazol, inhibidores de canales de sodio; y su uso para el tratamiento de un trastorno de dolor.
WO2007109456A3 (en) Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
ATE487713T1 (de) Neue tricyclische angiotensin-ii-agonisten
PE20071062A1 (es) Antibioticos de carbonatos de fenicol
WO2008009924A3 (en) Indoles useful in the treatment of inflammation
FR2923998B1 (fr) Etui d'application d'un raisin de rouge a levres comprenant un systeme d'association magnetique reversible de la base sur le mecanisme.
BRPI0814989A2 (pt) Triazolilpiridina cetonas herbicidas.
NO20075618L (no) Novel compounds as GLP-1 Agonists
ATE362367T1 (de) Phenoxyessigsäure-derivate als peroxisom- proliferator-aktivierte rezeptor (ppar) dual- agonisten
DE602005015120D1 (de) Kühlvorrichtung
JP2010527364A5 (ru)
CL2008003005A1 (es) Uso de la etilamina del acido 5-(2,4-dihidroxi-5-isopropil-fenil)-4-(4-morfolin-4-ilmetil-fenil)-isoxazol-3-carboxilico, una sal, hidrato o solvato del mismo para preparar un medicamento util en el tratamiento de diferentes tipos de cancer.
RU2010119919A (ru) Кристаллические химиотерапевтические средства
BRPI0606178A2 (pt) derivados de 3-aril-1,2-benzisoxazol e sua utilização como medicamentos contra o cáncer
ATE406815T1 (de) Schliesszylinder für einen strangheftapparat
SE0502257L (sv) Värmepump med turbokompressor som drivs av systemets köldmedium
TH79584A (th) แอนิลิโน-ไพริมิดีน แอนาล็อก

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160526